|
End-of-day quote
Buenos Aires S.E.
2026-11-03
|
5-day change | 1st Jan Change | ||
| 140.00 ARS | +2.94% |
|
+3.32% | -41.79% |
| Market Cap | 5.96B 3.85M 3.43M 3.15M 2.87M 5.38M 364M 5.52M 37.67M 15.14M 192M 14.44M 14.13M 610M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 6.7B 4.32M 3.86M 3.54M 3.22M 6.05M 409M 6.2M 42.33M 17.02M 216M 16.22M 15.87M 686M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.94% | ||
| 1 week | +3.32% | ||
| Current month | +1.08% | ||
| 1 month | -0.36% | ||
| 3 months | -12.23% | ||
| 6 months | -15.15% | ||
| Current year | -41.79% |
| 1 week | 130 |  | 144 |
| 1 month | 130 | | 154 |
| Current year | 128.5 | | 260 |
| 1 year | 128.5 | | 357 |
| 3 years | 46 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.94% | +3.32% | -13.04% | +192.28% | 3.75M | |
| -0.11% | +10.18% | +63.34% | +142.88% | 1,257B | |
| -1.62% | -0.05% | +40.93% | +77.16% | 651B | |
| -0.98% | -0.26% | +31.17% | +99.64% | 510B | |
| -1.56% | -1.39% | +51.02% | +64.18% | 388B | |
| -2.49% | +2.89% | +68.26% | +40.66% | 366B | |
| -0.02% | +3.15% | +32.47% | +55.33% | 303B | |
| -0.72% | +7.05% | +10.34% | +32.79% | 288B | |
| -0.90% | +3.74% | +54.56% | +73.02% | 252B | |
| -1.68% | +5.53% | +39.80% | +106.17% | 211B | |
| Average | -0.49% | +4.43% | +37.89% | +88.41% | 422.67B | |
| Weighted average by Cap. | -0.50% | +5.30% | +47.77% | +91.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.34M 4.77M 4.38M 3.98M 7.47M 506M 7.66M 52.28M 21.02M 267M 20.03M 19.6M 847M | 6.4B 4.13M 3.69M 3.39M 3.08M 5.78M 391M 5.93M 40.46M 16.27M 207M 15.5M 15.17M 655M |
| Net income | -1.42B -914K -816K -750K -682K -1.28M -86.59M -1.31M -8.95M -3.6M -45.72M -3.43M -3.36M -145M | -4.6B -2.97M -2.65M -2.43M -2.21M -4.15M -281M -4.26M -29.05M -11.68M -148M -11.13M -10.89M -471M |
| Net Debt | 863M 557K 497K 457K 415K 779K 52.74M 799K 5.45M 2.19M 27.84M 2.09M 2.04M 88.34M | 738M 476K 425K 390K 355K 666K 45.07M 683K 4.66M 1.87M 23.8M 1.79M 1.75M 75.5M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-03 | ARS 140.00 | +2.94% | 200 |
| 26-11-02 | ARS 136.00 | -1.81% | 3,263 |
| 26-10-30 | ARS 138.50 | -0.72% | 10,354 |
| 26-10-29 | ARS 139.50 | +2.57% | 1,200 |
| 26-10-28 | ARS 136.00 | -0.37% | 10,969 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
